Natalia Marueva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalia Marueva has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Natalia Shnayder
Institute of Personalized Psychiatry and Neurology, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, 3 Bekhterev St., 192019 St. Petersburg, Russia
3 shared publications - A. Yu. Ma-Van-De
Chita State Medical Academy
2 shared publications - Yuri A. Shirshov
Chita State Medical Academy
2 shared publications A.V. Shulmin
1 shared publicationAndrei Shulmin
1 shared publicationArray V. Duyzhakova
Krasnoyarsk State Medical University named after Professor V. F. Voino-Yasenetsky
1 shared publication
Latest Publications
- Open Access
- 18 November 2024
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 3,p. 53-59
ANTIEPILEPTIC DRUG EFFICACY IN CERTAIN GENETIC TYPES OF CHILDHOOD EPILEPSY
Objective: we aimed to study antiepileptic drug efficacy in achieving seizure remission in certain genetic types of childhood epilepsy.Materials and methods. The authors studied 240 patients aged from 1 month to 18 years with epilepsy between 2019 and 2023. Children with genetic forms of epilepsy accounted for 69 (28,8%). In this group, remission was achieved in 13 (18,8%) of patients. Among them, there were 13 children (%) with certain forms of genetic epilepsy aged 5 to 4 (average 10 ± years), with 7 (53,8%) being girls and 6 (46,2%) being boys. There were 7 (53,8%) children with generalized epilepsy, including 5 (30,8%) cases of childhood absentee epilepsy. 5 (38,5%) patients had focal epilepsy, all of them had self-controlling epilepsy with central temporal adhesions. The study included one patient with an unspecified type of epilepsy (7.7%).Results. The duration of remission ranged from 6 months to 7 years 2 months (me – 3 years 8 months). 11 children (84,6%) were in stable remission for 1 year or longer. Complete clinical electroencephalographic remission was observed in 7 (53,9%) cases. In other cases, regional and diffuse epileptiform activity was recorded in 3 (75,0%) and 1 (25,0%) case, respectively. Remission was achieved in 5 children (38,5%) who were taking levetiracetam, 6 subjects (46,1%) – valproic acid, 1 person – carbamazepine (7,7%). Persistent remission was registered in 4 children (36,3%) who were prescribed levetiracetam, 5 children (45,4%) taking valproic acid and 1 person (9 %) who was administered carbamazepine. 1 person (7,7%) was in stable remission after discontinuation of the antiepileptic drug.Conclusion. Most of the children with certain types of genetic epilepsy under the treatment with antiepileptic drugs were in stable seizure remission. More than half of those observed were in a complete clinical electroencephalographic remission. Predominantly, seizure remission occurred with the administration of valproic acid and levetiracetam, with the same frequency in generalized and focal types of genetic epilepsy.
- 18 November 2024
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 3,p. 53-59
Open AccessANTIEPILEPTIC DRUG EFFICACY IN CERTAIN GENETIC TYPES OF CHILDHOOD EPILEPSY
Objective: we aimed to study antiepileptic drug efficacy in achieving seizure remission in certain genetic types of childhood epilepsy.Materials and methods. The authors studied 240 patients aged from 1 month to 18 years with epilepsy between 2019 and 2023. Children with genetic forms of epilepsy accounted for 69 (28,8%). In this group, remission was achieved in 13 (18,8%) of patients. Among them, there were 13 children (%) with certain forms of genetic epilepsy aged 5 to 4 (average 10 ± years), with 7 (53,8%) being girls and 6 (46,2%) being boys. There were 7 (53,8%) children with generalized epilepsy, including 5 (30,8%) cases of childhood absentee epilepsy. 5 (38,5%) patients had focal epilepsy, all of them had self-controlling epilepsy with central temporal adhesions. The study included one patient with an unspecified type of epilepsy (7.7%).Results. The duration of remission ranged from 6 months to 7 years 2 months (me – 3 years 8 months). 11 children (84,6%) were in stable remission for 1 year or longer. Complete clinical electroencephalographic remission was observed in 7 (53,9%) cases. In other cases, regional and diffuse epileptiform activity was recorded in 3 (75,0%) and 1 (25,0%) case, respectively. Remission was achieved in 5 children (38,5%) who were taking levetiracetam, 6 subjects (46,1%) – valproic acid, 1 person – carbamazepine (7,7%). Persistent remission was registered in 4 children (36,3%) who were prescribed levetiracetam, 5 children (45,4%) taking valproic acid and 1 person (9 %) who was administered carbamazepine. 1 person (7,7%) was in stable remission after discontinuation of the antiepileptic drug.Conclusion. Most of the children with certain types of genetic epilepsy under the treatment with antiepileptic drugs were in stable seizure remission. More than half of those observed were in a complete clinical electroencephalographic remission. Predominantly, seizure remission occurred with the administration of valproic acid and levetiracetam, with the same frequency in generalized and focal types of genetic epilepsy.
- Open Access
- 18 November 2024
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 3,p. 93-99
THE ROLE OF INDIVIDUAL NEUROINFLAMMATION MOLECULES IN PATHOGENESIS ISCHEMIC STROKE. PART II
The problem of cerebrovascular diseases, in particular acute cerebrovascular accident, does not lose its relevance. Despite the primary and secondary prevention of cardiovascular diseases, the incidence of ischemic stroke among the population of the Russian Federation remains high. A well-established system of routing patients with acute vascular accidents and a multidisciplinary approach to treatment do not always guarantee a satisfactory result. The widespread prevalence of the disease, a high degree of disability and mortality, a decrease in the age of patients, economic losses associated with the rehabilitation of patients and their long-term disability dictate the need to find new and effective approaches to the diagnosis and treatment of this condition.Currently conducted studies are aimed at studying the pathogenetic cascade of reactions that occur at the time of acute cerebral ischemia, in order to develop adjuvant therapy. Based on the results obtained, additional options are being developed in the treatment and further rehabilitation of patients. The presented literature review collects and analyzes current data on the problem of ischemic stroke. The role of individual molecules of the tumor necrosis factor family, which are directly involved in the development and course of cerebral infarction, but also affect the further prognosis of survival and recovery of patients, is considered.
- 18 November 2024
- Published by Chita State Medical Academy in Transbaikalian Medical Bulletin
- No. 3,p. 93-99
Open AccessTHE ROLE OF INDIVIDUAL NEUROINFLAMMATION MOLECULES IN PATHOGENESIS ISCHEMIC STROKE. PART II
The problem of cerebrovascular diseases, in particular acute cerebrovascular accident, does not lose its relevance. Despite the primary and secondary prevention of cardiovascular diseases, the incidence of ischemic stroke among the population of the Russian Federation remains high. A well-established system of routing patients with acute vascular accidents and a multidisciplinary approach to treatment do not always guarantee a satisfactory result. The widespread prevalence of the disease, a high degree of disability and mortality, a decrease in the age of patients, economic losses associated with the rehabilitation of patients and their long-term disability dictate the need to find new and effective approaches to the diagnosis and treatment of this condition.Currently conducted studies are aimed at studying the pathogenetic cascade of reactions that occur at the time of acute cerebral ischemia, in order to develop adjuvant therapy. Based on the results obtained, additional options are being developed in the treatment and further rehabilitation of patients. The presented literature review collects and analyzes current data on the problem of ischemic stroke. The role of individual molecules of the tumor necrosis factor family, which are directly involved in the development and course of cerebral infarction, but also affect the further prognosis of survival and recovery of patients, is considered.
- 1 January 2017
- Published by Krasnoyarsk State Medical University in Siberian Medical Review
- No. 1,p. 44-48
ASSESSMENT OF EPILEPSY PUBLIC AWARENESS IN CHILDREN AMONG TEACHERS OF THE REHABILITATIVE INSTITUTIONS
- 1 January 2017
- Published by Krasnoyarsk State Medical University in Siberian Medical Review
- No. 1,p. 44-48
ASSESSMENT OF EPILEPSY PUBLIC AWARENESS IN CHILDREN AMONG TEACHERS OF THE REHABILITATIVE INSTITUTIONS
- Open Access
- 1 August 2016
- Published by Contemporary Clinical Medicine in The Bulletin of Contemporary Clinical Medicine
- Vol. 9 (4) , 32-38
EVALUATION OF A SPECIALIZED MEDICAL CARE OF CHILDREN WITH EPILEPSY AND SEIZURE SYNDROMES IN TRANSBAIKAL REGION
- 1 August 2016
- Published by Contemporary Clinical Medicine in The Bulletin of Contemporary Clinical Medicine
- Vol. 9 (4) , 32-38
Open AccessEVALUATION OF A SPECIALIZED MEDICAL CARE OF CHILDREN WITH EPILEPSY AND SEIZURE SYNDROMES IN TRANSBAIKAL REGION
- Open Access
- 1 January 2016
- Published by IRBIS in Epilepsy and paroxysmal conditions
- Vol. 8 (3) , 27-33
FREQUENCY OF CLINICAL PHENOTYPES OF JUVENILE MYOCLONIC EPILEPSY: PILOT STUDY IN SIBERIAN FEDERAL DISTRICT
Objective. The analysis of the frequency of occurrence of clinical phenotypes of JME among residents of the Siberian Federal District (Russia). Materials and Methods. 80 patients with JME underwent preliminary anamnestic and clinical selection using stratified randomization. After verification of their diagnosis, patients were grouped based on the phenotype classification proposed by Martínez-Juárez et al (2006). Gender was also noted for subsequent genderrelated analysis. Results. The incidence of JME among males was lower than among females. In general, the average JME onset age was characteristic for this clinical form of idiopathic generalized epilepsy. Furthermore, JME onset age in males was higher than in females. In general, the most frequent phenotype was the classical Type I phenotype. The frequency of Type I occurrence in males was significantly higher than that in females. Type II, the least favorable phenotype in terms of stable pharmacological remission, occurred 3.5 times less frequently in males compared to females. Types III and IV did not reveal significant gender-related differences. Conclusions. The results allow to revise the initial diagnosis of JME in burdened families: we recommend video-EEG monitoring in adolescent female patients at a younger age, with mandatory testing of levels of consciousness during induced stress. Higher frequency of Type II JME in females suggests imminent need for dynamic and lengthy video-EEG monitoring to exclude the chance of pseudo remission, before a decision can be made about reduction or termination of AEDs.
- 1 January 2016
- Published by IRBIS in Epilepsy and paroxysmal conditions
- Vol. 8 (3) , 27-33
Open AccessFREQUENCY OF CLINICAL PHENOTYPES OF JUVENILE MYOCLONIC EPILEPSY: PILOT STUDY IN SIBERIAN FEDERAL DISTRICT
Objective. The analysis of the frequency of occurrence of clinical phenotypes of JME among residents of the Siberian Federal District (Russia). Materials and Methods. 80 patients with JME underwent preliminary anamnestic and clinical selection using stratified randomization. After verification of their diagnosis, patients were grouped based on the phenotype classification proposed by Martínez-Juárez et al (2006). Gender was also noted for subsequent genderrelated analysis. Results. The incidence of JME among males was lower than among females. In general, the average JME onset age was characteristic for this clinical form of idiopathic generalized epilepsy. Furthermore, JME onset age in males was higher than in females. In general, the most frequent phenotype was the classical Type I phenotype. The frequency of Type I occurrence in males was significantly higher than that in females. Type II, the least favorable phenotype in terms of stable pharmacological remission, occurred 3.5 times less frequently in males compared to females. Types III and IV did not reveal significant gender-related differences. Conclusions. The results allow to revise the initial diagnosis of JME in burdened families: we recommend video-EEG monitoring in adolescent female patients at a younger age, with mandatory testing of levels of consciousness during induced stress. Higher frequency of Type II JME in females suggests imminent need for dynamic and lengthy video-EEG monitoring to exclude the chance of pseudo remission, before a decision can be made about reduction or termination of AEDs.
- Open Access
- 1 January 2016
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- No. 1S,p. 54-58
The epidemiology of afebrile seizures in the pediatric population of the Trans-Baikal Territory
Цель – исследование эпидемиологии афебрильных приступов (АП) в детской популяции Забайкальского края с 2004 по 2013 г. Материалы и методы. Проведен ретроспективный анализ данных регистра пациентов с эпилепсией и судорожными синдромами детского возраста (фебрильные приступы и изолированный судорожный приступ) Забайкальского краевого противоэпилептического центра (КПЭЦ) за 2004–2013 гг. Результаты и обсуждение. Заболеваемость АП в Забайкальском крае со времени открытия КПЭЦ колебалась в пределах от 0,23 (64 случая в 2005 г.) до 0,49 (128 случаев в 2008 г.). Распространенность АП увеличилась с 1,37 (431 случай в 2004 г.) до 4,71 (1232 случая в 2013 г.) на 1000 детского населения. Распространенность и заболеваемость АП существенно не различались среди детей, проживающих в г. Чите и в районах Забайкальского края. Частота случаев АП в структуре регистра детей с эпилепсией и судорожными синдромами снизилась с 94,31% в 2004 г. до 83,19% в 2013 г. АП преобладали у детей в возрасте от 3 лет 1 мес до 7 лет. Соотношение частоты случаев АП среди мальчиков и девочек варьировало от 1:1,1 до 1,1:1.
- 1 January 2016
- Published by IMA Press, LLC in Neurology, Neuropsychiatry, Psychosomatics
- No. 1S,p. 54-58
Open AccessThe epidemiology of afebrile seizures in the pediatric population of the Trans-Baikal Territory
Цель – исследование эпидемиологии афебрильных приступов (АП) в детской популяции Забайкальского края с 2004 по 2013 г. Материалы и методы. Проведен ретроспективный анализ данных регистра пациентов с эпилепсией и судорожными синдромами детского возраста (фебрильные приступы и изолированный судорожный приступ) Забайкальского краевого противоэпилептического центра (КПЭЦ) за 2004–2013 гг. Результаты и обсуждение. Заболеваемость АП в Забайкальском крае со времени открытия КПЭЦ колебалась в пределах от 0,23 (64 случая в 2005 г.) до 0,49 (128 случаев в 2008 г.). Распространенность АП увеличилась с 1,37 (431 случай в 2004 г.) до 4,71 (1232 случая в 2013 г.) на 1000 детского населения. Распространенность и заболеваемость АП существенно не различались среди детей, проживающих в г. Чите и в районах Забайкальского края. Частота случаев АП в структуре регистра детей с эпилепсией и судорожными синдромами снизилась с 94,31% в 2004 г. до 83,19% в 2013 г. АП преобладали у детей в возрасте от 3 лет 1 мес до 7 лет. Соотношение частоты случаев АП среди мальчиков и девочек варьировало от 1:1,1 до 1,1:1.